Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 Study
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
|
| Series: | South Asian Journal of Cancer |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1802565 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832575510426681344 |
|---|---|
| author | Dinesh Chandra Doval Tanveer Maksud Rajnish Nagarkar Satheesh Chiradoni Thunagappa Rakesh Taran Saurabh Prasad Anoop T. Manoharan Minish Jain Dhruv Mehta Prabrajya Narayan Mohapatra Sachin Gupta Kritarth Naman Singh Aarohan Pruthi Rohit Arora |
| author_facet | Dinesh Chandra Doval Tanveer Maksud Rajnish Nagarkar Satheesh Chiradoni Thunagappa Rakesh Taran Saurabh Prasad Anoop T. Manoharan Minish Jain Dhruv Mehta Prabrajya Narayan Mohapatra Sachin Gupta Kritarth Naman Singh Aarohan Pruthi Rohit Arora |
| author_sort | Dinesh Chandra Doval |
| collection | DOAJ |
| format | Article |
| id | doaj-art-4e03698af7254048a3280452ef811e20 |
| institution | Kabale University |
| issn | 2278-330X 2278-4306 |
| language | English |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | South Asian Journal of Cancer |
| spelling | doaj-art-4e03698af7254048a3280452ef811e202025-02-01T00:00:34ZengThieme Medical and Scientific Publishers Pvt. Ltd.South Asian Journal of Cancer2278-330X2278-430610.1055/s-0045-1802565Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 StudyDinesh Chandra Doval0Tanveer Maksud1Rajnish Nagarkar2Satheesh Chiradoni Thunagappa3Rakesh Taran4Saurabh Prasad5Anoop T. Manoharan6https://orcid.org/0000-0003-0567-5253Minish Jain7Dhruv Mehta8Prabrajya Narayan Mohapatra9Sachin Gupta10Kritarth Naman Singh11Aarohan Pruthi12Rohit Arora13Department of Medical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, New Delhi, IndiaDepartment of Medical Oncology, Unique Hospital Multispecialty & Research Institute, Surat, Gujarat, IndiaDepartment of Surgical Oncology, HCG Manavata Cancer Centre, HCG Manavata Cancer Centre, Nashik, Maharashtra, IndiaDepartment of Medical Oncology, HCG Cancer Centre, Bengaluru, Karnataka, IndiaDepartment of Medical Oncology, SRJ-CBCC Cancer Hospital, Indore, Madhya Pradesh, IndiaDepartment of Medical Oncology, Kingsway Hospital, Nagpur, Maharashtra, IndiaDepartment of Medical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, IndiaDepartment of Medical Oncology, Grant Medical Foundation Ruby Hall Clinic, Pune, Maharashtra, IndiaDepartment of Medical Oncology, Nirmal Hospital Pvt. Ltd., Surat, Gujarat, IndiaDepartment of Medical Oncology, Apollo Gleneagles Hospital, Salt Lake, Kolkata, West Bengal, IndiaDepartment of Medical Oncology, Max Super Specialty Hospital, Chandigarh, IndiaClinical Research Physician (Oncology), Eli Lilly and Company (India) Pvt. Ltd., Gurgaon, Haryana, IndiaSenior Director - Medical (Oncology), Eli Lilly and Company (NAPAC), Sydney, AustraliaSenior Director - Medical Development, Eli Lilly Services India Private Limited, Bangalore, Karnataka, Indiahttp://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1802565breast cancerendocrine therapyCDK4/6 inhibitorsabemaciclibadvanced breast cancerIndia |
| spellingShingle | Dinesh Chandra Doval Tanveer Maksud Rajnish Nagarkar Satheesh Chiradoni Thunagappa Rakesh Taran Saurabh Prasad Anoop T. Manoharan Minish Jain Dhruv Mehta Prabrajya Narayan Mohapatra Sachin Gupta Kritarth Naman Singh Aarohan Pruthi Rohit Arora Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 Study South Asian Journal of Cancer breast cancer endocrine therapy CDK4/6 inhibitors abemaciclib advanced breast cancer India |
| title | Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 Study |
| title_full | Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 Study |
| title_fullStr | Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 Study |
| title_full_unstemmed | Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 Study |
| title_short | Safety of Abemaciclib in Indian Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced and/or Metastatic Breast Cancer: A Multicenter, Nonrandomized, Open-Label, Single-Arm, Phase 4 Study |
| title_sort | safety of abemaciclib in indian patients with hormone receptor positive human epidermal growth factor receptor 2 negative locally advanced and or metastatic breast cancer a multicenter nonrandomized open label single arm phase 4 study |
| topic | breast cancer endocrine therapy CDK4/6 inhibitors abemaciclib advanced breast cancer India |
| url | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1802565 |
| work_keys_str_mv | AT dineshchandradoval safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study AT tanveermaksud safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study AT rajnishnagarkar safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study AT satheeshchiradonithunagappa safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study AT rakeshtaran safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study AT saurabhprasad safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study AT anooptmanoharan safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study AT minishjain safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study AT dhruvmehta safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study AT prabrajyanarayanmohapatra safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study AT sachingupta safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study AT kritarthnamansingh safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study AT aarohanpruthi safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study AT rohitarora safetyofabemaciclibinindianpatientswithhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativelocallyadvancedandormetastaticbreastcanceramulticenternonrandomizedopenlabelsinglearmphase4study |